跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
澳博灵 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ampicillin and Cloxacillin Sodium Capsules
Approved
化学药品
Ampicillin and Cloxacillin Sodium Capsules
澳美製藥廠有限公司
🇨🇳 National Medical Products Administration
Approval Date
Aug 5, 2022
Approval ID
648ead360d4b46cd
Company
澳美製藥廠有限公司
Type
化学药品
Approval Details
Approval Id
648ead360d4b46cd
Approval Number
国药准字HC20171012
Generic Name
氨苄西林氯唑西林钠胶囊
Generic Name En
Ampicillin and Cloxacillin Sodium Capsules
Brand Name
澳博灵
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.5g(氨苄西林(按C₁₆H₁₉N₃O₄S计)0.25g与氯唑西林(C₁₉H₁₈ClN₃O₅S)0.25g)
Reg Date
2022-08-05
Expired Date
2027-08-04
Company Name
澳美製藥廠有限公司
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街8号澳美制药中心
Company Detail Path
/organization/ao-mei-zhi-yao-chang-you-xian-gong-si
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 5, 2022
Approval ID
648ead360d4b46cd
Type
化学药品
Back to NMPA Approvals